Abstract: This computational data processing system comprises an assembly of networked computers (12, . . . 22) in each of which is stored at least one computational application, and a machine (10) for storing computational data which is linked to the network and in communication with the computers, at least one of the computers (12) operating as master computer and at least some of the other computers (14, . . . 22) operating as slave computer. At least one of the computers comprises, stored in memory an algorithm for configuring the other computers of the network as slave computers and an executable master application for managing the tasks of each slave computer (14, . . . 22) as a function of their availability for the assignment, to each of them, of computational tasks and of corresponding computational data which are stored in the storage machine (10).
Type:
Grant
Filed:
March 15, 2001
Date of Patent:
January 2, 2007
Assignee:
LIPHA
Inventors:
Edouard Viollet, Thierry Convard, Jacques Barbanton
Abstract: The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. Said compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
Abstract: The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. The compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
Abstract: A pharmaceutical composition for the treatment of alcohol and drug dependence, comprising a therapeutically effective amount of a combination of: (i) an opioid antagonist; and (ii) a NMDA receptor complex modulator. A pharmaceutical kit is also provided, comprising these two substances. The opioid antagonist can, for example, be naltrexone and the NMDA receptor complex modulator can be a spermidine site modulator such as acamprosate.
Type:
Grant
Filed:
January 12, 2001
Date of Patent:
January 28, 2003
Assignee:
Lipha
Inventors:
Martine Daoust, Yves Bonhomme, Philippe Durbin
Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
Type:
Grant
Filed:
July 14, 1999
Date of Patent:
October 16, 2001
Assignee:
LIPHA
Inventors:
Yves Bonhomme, Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson
Abstract: This computational data processing system comprises an assembly of networked computers (12, . . . 22) in each of which is stored at least one computational application, and a machine (10) for storing computational data which is linked to the network and in communication with the computers, at least one of the computers (12) operating as master computer and at least some of the other computers (14, . . . 22) operating as slave computer. At least one of the computers comprises, stored in memory an algorithm for configuring the other computers of the network as slave computers and an executable master application for managing the tasks of each slave computer (14, . . . 22) as a function of their availability for the assignment, to each of them, of computational tasks and of corresponding computational data which are stored in the storage machine (10).
Type:
Application
Filed:
March 15, 2001
Publication date:
September 20, 2001
Applicant:
Lipha
Inventors:
Edouard Viollet, Thierry Convard, Jacques Barbanton
Abstract: Derivatives of sulphonic aminoalkane acids, corresponding to formula (I)
where X is
R1, R2 and R3 are selected from hydrogen and a C1-C7 alkyl radical, and A is a group of the formula (e) where v and w are 0, 1, 2 or a group of formula (f) where R5 and R6 are selected independently of each other from hydrogen, a C1-C7 alkyl radical, an aryl radical having between 6 and 14 carbon atoms and a heteroaryl radical; t is 1-3; R4 is selected from hydrogen, a C1-C7 alkyl radical, a CF3 radical, an aryl radical having between 6 and 14 carbon atoms and a heteroaryl radical; M is a monovalent metal (Na, K, Li) or a divalent metal (Ca, Mg, Sr, Zn); m is 1 or 2; p is 1-2 and q is 1-2; and where p and q are such that the electrical neutrality of the salt is ensured. The compounds can be used for the treatment of alcohol dependence.
Type:
Grant
Filed:
October 12, 2000
Date of Patent:
July 24, 2001
Assignee:
LIPHA
Inventors:
Jean-Jacques Berthelon, Philippe Durbin